Related Experiment Video
Updated: Feb 28, 2026

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Impact of Acute (Poly)Phenol-Rich Sugarcane Extract Consumption on Postprandial Glycemic Response in Healthy Adults:
Ulluwis H A J Hewawansa1,2, Elizabeth Barber1,2, Michael J Houghton1,2
1Department of Nutrition, Dietetics and Food, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, 264 Ferntree Gully Road, Notting Hill, VIC 3168, Australia.
Abstract:
Background: Effects on insulin sensitivity and postprandial glycemia through enzyme inhibition and regulation of glucose transport have been extensively researched; however, the role of sugarcane (poly)phenols remain underexplored. Methods: In a randomized, placebo-controlled, single-blinded crossover study, 12 healthy participants consumed a bread-based meal containing 50 g of carbohydrates, supplemented with either 0.5% or 5% liquid PRSE or sugar-balanced controls. Glucose and plasma insulin levels were assessed over 180 min. The extract was evaluated for its inhibitory effect on human α-amylases (salivary and pancreatic) and α-glucosidases (sucrase, maltase, and isomaltase) utilizing solid PRSE. Results: The postprandial glucose and insulin responses to bread sandwiches in healthy volunteers remained unchanged by both PRSE dosages. High-dose treatment reduced the Matsuda index by 9.8%, perhaps due to a subtle alteration in whole-body insulin sensitivity. Low-dose intervention postponed the insulin peak by 30 min without altering HOMA-IR. In vitro, PRSE diminished sucrase activity by 67% (IC50 = 425.8 ± 18.7 µg/mL) and lowered maltase and isomaltase activity by 40% (IC25 = 876.3 ± 131 and 960.6 ± 95.2 µg/mL, respectively). It enhanced the activity of human salivary and pancreatic α-amylases. Conclusion: In healthy people, acute PRSE supplementation had a minor impact on postprandial glucose and insulin levels. Low-dose PRSE postponed the insulin peak, whereas high-dose PRSE reduced Matsuda index potentially via α-amylase activation, suggesting a modest alteration in whole-body insulin sensitivity without significantly changing the glucose or insulin response. In vitro, PRSE exhibited modest inhibition of human α-glucosidases.
More Related Videos
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Bioavailability Study Design: Healthy Subjects Versus Patients
Oral Hypoglycemic Agents: Biguanides and Glitazones
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Absorption Into the Small Intestine